Tisotumab Vedotin

Category: Cancer

Tisotumab vedotin, sold under the brand name Tivdak, is an antibody-drug conjugate used to treat cervical cancer.[1] It is a combination of tisotumab, a monoclonal antibody against tissue factor, and monomethyl auristatin E (MMAE), a potent inhibitor of cell division. Tisotumab vedotin was approved for medical use in the United States in September 2021.[1][2] It is administered by infusion into a vein every 3 weeks.[1] Tisotumab ... [wikipedia]

Related Brands

Drugs with the same active ingredients